Introduction {#Sec1}
============

It is well known that the gastrointestinal (GI) tract is unique with respect to the arrangement of its innervation. The regulation of the stomach and gut is controlled by the enteric nervous system (ENS) which is distributed in the intramural ganglia (Brown and Timmermans [@CR7]). The ENS is capable of acting almost independently from other parts of the nervous system, but some functions of GI tract are also regulated by extrinsic autonomic innervation. Autonomic neurons supplying the stomach and gut are localized within the prevertebral or paravertebral ganglia and are involved in the regulation of motility, secretion, and blood flow within the organs mentioned above (Brown and Timmermans [@CR7]; Furness [@CR17]; Luckensmeyer and Keast [@CR28]). Previous investigations have shown that the main source of colon autonomic innervation originates from the inferior mesenteric ganglion (IMG) (Dalsgaard and Elfvin [@CR12]; Li and Masuko [@CR26]; Pidsudko et al. [@CR37]; Wojtkiewicz et al. [@CR52]). These IMG neurons supplying the GI tract co-localize several neurotransmitters and/or neuromodulators (Li and Masuko [@CR26]; Pidsudko et al. [@CR37]; Trudrung et al. [@CR47]; Wojtkiewicz et al. [@CR52]).

The neuropeptide calbindin (CB) was first identified in the intestines of the chicken (Wasserman et al. [@CR50]) and later studies have identified CB within intramural and extrinsic enteric neurons (Li and Masuko [@CR26], [@CR27]; Resibois et al. [@CR41]; Wojtkiewicz et al. [@CR52]). However, the role of CB in the GI tract has not yet been fully elucidated. CB belongs to a family of calcium-binding proteins and is thought to play a major role in buffering intracellular Ca^2+^ and various Ca^2+^-mediated signaling pathways (Cho et al. [@CR8]). Neuronal calcium could have a significant role in neuronal survival as well as programmed cell death and pathological neuronal damage but this remains controversial. Neurons rich in CB seem to be relativity resistant to damage or degeneration in a variety of acute and chronic diseases (Bastianelli [@CR4]). Previous studies on CB immunoreactivity in the ENS advocate that calbindin co-localizes with many neurochemical substances and could be used as an identifying marker for a specialized subpopulation of neurons within the ENS (Brown and Timmermans [@CR7]; Furness [@CR17]). It is also known that both intramural neurons of the ENS and the autonomic extrinsic neurons innervating the GI tract are able to change their structural, functional, or chemical phenotype as an adaptive response to various physiological and pathological stimuli, such as a diet, ontogenesis, or intestinal and extraintestinal diseases (Balemba et al. [@CR3]; Ekblad [@CR15]; Gonkowski and Calka [@CR21]; Lakomy et al. [@CR23]; Phillips and Powley [@CR36]; Pidsudko et al. [@CR38]; Vasina et al. [@CR48]). Contrary to intramural enteric neurons, there is a paucity of data regarding the plasticity of autonomic extrinsic neurons supplying the GI tract, especially in the porcine animal model (Lakomy et al. [@CR23]; Wojtkiewicz et al. [@CR52]). The structure and distribution of the porcine enteric neurons closely resemble those of the human in respect of anatomical, physiological, and pathological characteristics (Brown and Timmermans [@CR7]). Moreover, most of the data on the ENS and extrinsic innervation plasticity in pathological states have been acquired using experimental models, where different agents have been applied into the lumen of the gut or injected into the colon wall (for review, see Biasi et al. [@CR5]; Elson et al. [@CR16]). However, the data concerning neurochemical changes in the ENS during "natural" inflammation associated with diseases affecting the alimentary system are rather limited (Pidsudko et al. [@CR38]).

Proliferative entheropathy (PE) is an intestinal disease that can induce significant changes in the chemical coding of intramural enteric neurons (Pidsudko et al. [@CR38]). Although the disease was originally described in 1931 (McOrist and Lawson [@CR32]), its ethological agent---the intracellular bacterium *Lawsonia intracellularis* was only identified in the 1990s (Lawson et al. [@CR25]). Contrary to other inflammatory diseases of the alimentary tract, PE is characterized by proliferative changes, such as hyperplasia of immature epithelial cells in different parts of intestinal tract, most frequently within the ileum and colon (Lawson and Gebhart [@CR24]; Smith and Lawson [@CR43]). Moreover, this disease is characterized by epithelial cell degeneration, necrosis, and sometimes ulceration or hemorrhage (Lawson and Gebhart [@CR24]). Until now, the available data regarding the influence of PE on the immunoreactivity of extrinsic enteric neurons are lacking and few studies have addressed this issue (Wojtkiewicz et al. [@CR51]).

The aim of this study was to identify the number and neurochemical characterization of CB-containing neurons of IMG supplying the porcine descending colon and to further analyze their plastic capacity during proliferative enteropathy.

Material and Methods {#Sec2}
====================

Animals {#d29e427}
-------

The study was performed on six immature female pigs of the Large White Polish breed (approximately 8 weeks old) divided into two groups: control animals (C group; *n* = 3) and animals with clinically diagnosed *L. intracellularis* infection (PE group; *n* = 3). The animals of the PE contracted the *L. intracellularis* infection by housing them in a herd, in which the infection has previously been detected and characterized chronically. Thus, as described below, six animals were retrogradely traced and then housed together with animals recently diagnosed with chronic PE. After 2 weeks, the animals were examined by a veterinary surgeon, and subjects with suspected PE were entered into the experimental group. The diagnosis of PE was then confirmed by post-mortem using a polymerase chain reaction-based test performed at the State Veterinary Research Institute in Pulawy (Poland). All animals were housed and treated in accordance with the Principles of Laboratory Animal Care, NIH publication no. 86-23, revised 1985. The surgical and experimental procedures were approved by the Ethics Committee in Olsztyn (Poland).

Anesthesia and Surgery {#d29e444}
----------------------

Surgery was performed under fractionated thiobarbital (Thiopenthal, Sandoz, Austria; 20 mg/kg b.w., i.v.) anesthesia. Prior to administration (30 min) of the main anesthetic, the animals were pretreated with atropine sulphate (Polfa, Poland; 0.04 mg/kg b.w., s.c.) and azaperone (Stressnil, Janssen Pharmaceutica, Belgium; 2.0 mg/kg b.w., i.m.). All animals (*n* = 6) were laparotomized and injected with 5% aqueous solution of the fluorescence retrograde neuronal tracer fast blue (FB; Dr. K. Illing GmbH, Gross-Umstadt, Germany) into wall of the descending colon. A total volume of 40 μl of 5% aqueous dye solution was injected into the exposed descending colon using a Hamilton syringe with a 26-gauge needle. Multiple (*n* = 40; 1 μl each) injections were made into the right part of descending colon. After 3 weeks, all animals (C and PE) were re-anesthetized as described above and euthanized by overdosage of thiobarbital and transcardially perfused with 4% buffered paraformaldehyde (pH 7.4). Following the perfusion, small tissue blocks comprising the IMG were collected from all studied animals, postfixed by immersion in the same fixative for 4 h, washed twice in 0.1 M phosphate buffer (pH = 7.4, 4°C) and then stored in 18% sucrose at 4°C until sectioning.

Immunofluorescence Experiments {#d29e455}
------------------------------

Ten-micrometer thick cryostat sections of IMGs were processed for routine double-immunofluorescence labeling using primary antisera raised in different species and species-specific secondary antibodies (Table. [1](#Tab1){ref-type="table"}). Briefly, all sections were incubated in humid chambers with a mixture of two primary antisera raised in different species (overnight). The mixture consisted of antibodies directed towards calbindin-D28k (CB) and antisera raised against tyrosine hydroxylase (TH) or neuropeptide Y (NPY) or somatostatin (SOM) or vasoactive intestinal polypeptide (VIP) or nitric oxide synthase (NOS) or leu(5)-enkephalin (LENK) or substance P (SP) or vesicular acetylcholine transporter (VAChT) or galanin (GAL), or pituitary adenylate cyclase-activating polypeptide (PACAP) (Table. [1](#Tab1){ref-type="table"}). Then sections were incubated with a mixture of FITC-conjugated secondary antisera and biotin (1 h). The latter antibodies were visualized by additional incubation of the sections with streptavidin--CY3 complex (1 h). After staining, the sections were mounted with carbonate-buffered glycerol (pH 8.6) and applied with cover slips. Each step of the immunolabeling was followed by rinsing with PBS (3 × 15 min).Table 1Specification of immunoreagentsAntigenCodeHost speciesDilutionSupplierPrimary antibodiesCBCB-38Rabbit1:20,000SWANTTHMAB 318Mouse1:80ChemiconNPYNZ1115Rat1:300BiomolSOM8330-0009Rat1:100BiogenesisVIP9535-0504Mouse1:2,000BiogenesisNOSN2280Mouse1:2,000SigmaLENK4140-0355Mouse1:1,000BiogenesisSP8450-0505Rat1:300BiogenesisVAChTH-V007Goat1:2,000PhoenixGALT-5036Guinea Pig1:1,000PeninsulaPACAPT-5039Guinea Pig1:1,000PeninsulaSecondary reagentsDonkey anti-mouse IgG (H + L) conjugated with FITC1:800JacksonDonkey anti-rat IgG (H + L) conjugated with FITC1:800JacksonDonkey anti-guinea pig IgG (H + L) conjugated with FITC1:1,000JacksonDonkey anti-goat IgG (H + L) conjugated with FITC1:1,000JacksonBiotinylated goat anti-rabbit immunoglobulins1:1,000DAKOBiotin conjugated F(ab)' fragment of affinity purified anti-rabbit IgG (H + L)1:1,000BioTrendCY3-conjugated Streptavidin1:9,000Jackson

Controls {#d29e753}
--------

Standard controls, i.e., preabsorption for the neuropeptide antisera (20 mg of appropriate antigen per 1 ml of corresponding antibody at working dilution), and the omission and replacement of all primary antisera by non-immune sera or PBS were applied to test both antibody- and method specificity.

Counting and Statistics {#d29e758}
-----------------------

The sections were viewed under an Olympus BX51 fluorescence microscope equipped with a barrier filter for FB. Images were acquired by a PC equipped with Olympus CellSens image analyzing software (Olympus Japan). To determine the relative number of FB/CB-positive cells, the neurons were counted in every 16th section. Approximately 560 FB^+^ neurons were analyzed per animal. Cells devoid of FB^+^ were not counted and only neurons with a clearly visible nucleus were scored. Data pooled from two different animals groups were expressed as means ± standard error of mean (SEM) and were analyzed by using GraphPad Prism 5 software (GraphPad Software, La Jolla, CA, USA).

Results {#Sec3}
=======

The porcine IMG contained retrogradely labeled neurons projecting to the descending colon (FB^+^); these were distributed bilaterally, i.e., within both left and the right ganglia. In each of these ganglia, FB^+^/CB^+^ cells formed neurochemically heterogenous population composed of neurons using various substances as their main neurotransmitters (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, and [3](#Fig3){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}). In animals with proliferative enteritis, the size of the whole population of FB^+^ neurons did not change; however, the coding patterns of many FB^+^/CB^+^ cells were changed (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}).Fig. 1Representative images of colon-projecting neurons located in IMG of the control animals (C, a--l); and animals with *L. intracellularis* infection (PE, a'--l'). Figure parts d, d', h, h', l, l' are composites of merged images taken separately from *blue* (a, a', e, e', i, and i'), *red* (b, b', f, f', j, and j') and *green* (c, c', g, g', k, k') fluorescent channels. *Scale bar* in each figure parts = 50 μm. **a--d** and **a'--d'**---FB^+^/CB^+^/TH^+^ neurons in C and PE animals, respectively. Note the similar number of FB^+^ (a and a') and FB^+^/CB^+^/TH^+^ (d and d') neurons in C and PE animals, respectively (*small arrows*). Some FB^+^ neurons in both animal groups were CB negative (*long arrow*). **e--h** and **e'--h'**---FB^+^/CB^+^/NPY^+^ neurons in C and PE animals, respectively. Note an increased number of FB^+^/CB^+^/NPY^+^ (h and h') neurons in PE animals (*small arrows*). FB^+^/CB^+^/NPY^+^---*small arrows*, FB^+^/CB^+^/NPY^−^---*double arrows*, FB^+^/CB^−^/NPY^+^---*long arrows*. **i-l** and **i'-l'**---FB^+^/CB^+^/SOM^+^ neurons in C and PE animals, respectively. Note strong reduction in the number of SOM^+^ (k and k') and FB^+^/CB^+^/SOM^+^ (l and l') neurons in PE animals (*small arrows*). FB^+^/CB^+^/SOM^+^---*small arrows*, FB^+^/CB^+^/SOM^−^---*double arrows*, FB^+^/CB^−^/SOM^+^---*long arrows*Fig. 2Representative images of colon-projecting neurons located in IMG of the control animals (C, a--l); and animals with *L. intracellularis* infection (PE, a'--l'). Figure parts d, d', h, h', l, and l' are composites of merged images taken separately from *blue* (a, a', e, e', i, and i'), *red* (b, b', f, f', j, and j') and *green* (c, c', g, g', k, and k') fluorescent channels. *Scale bar* in each figure parts = 50 μm. **a--d** and **a'--d'**---FB^+^/CB^+^/VIP^+^ neurons in C and PE animals, respectively. FB^+^/CB^+^/VIP^+^---*small arrows*, FB^+^/CB^+^/VIP^−^---*double arrows*. **e--h** and **e'--h'**---note the lack of FB^+^/CB^+^/NOS^+^ (h and h') neurons in C and PE animals and strong reduction in the number of NOS^+^ (g and g') neurons in PE animals. FB^+^/CB^+^/NOS^−^---*double arrows*, FB^+^/CB^−^/NOS^+^---*long arrows*. **i--l** and **i'--l'**---note the lack of FB^+^/CB^+^/LENK^+^ (l and l') neurons in C and PE animals. FB^+^/CB^+^/ LENK^−^---*double arrows*Fig. 3Diagram illustrating the FB^+^/CB^+^ cell numbers which were immunoreactive to appropriate antigens in IMGs of control (*light grey bars*) and PE animals (*dark grey bars*) (in percent). Student\'s *t* test, \*\*\**P* ≤ 0.001, \*\**P* ≤ 0.01, \**P* ≤ 0.05Table 2Relative frequencies of the main subsets of CB^+^/FB^+^ neurons in the inferior mesenteric ganglia of control and PE animalsFB^+^/CB^+^/P^+^CPETH93.0 ± 2.493.0 ± 1.4NPY72.1 ± 3.282.3 ± 2.3SOM36.9 ± 3.516.4 ± 1.1VIP3.2 ± 0.80NOS00LENK00SP00VAChT00GAL00PACAP00P stands for "peptide" (e.g., NPY, SOM, VIP etc.)

In control animals, FB/CB-positive neurons supplying the colon formed a morphologically and neurochemically heterogeneous population of neurons (Fig. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, and [3](#Fig3){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}). The majority of these neurons were immunoreactive for tyrosine hydroxylase and neuropeptide Y (Fig. [1a--h](#Fig1){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}). Another large subpopulation of FB^+^/CB^+^ neurons were those containing SOM. These cells constituted almost 37% of FB^+^/CB^+^ neurons (Fig. [1i--l](#Fig1){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}). A small subpopulations of FB/CB-positive neurons co-expressed vasoactive intestinal peptide (3%; Fig. [2a--d](#Fig2){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}). In the animals with clinically diagnosed *L. intracellularis* infection, the numbers of FB/CB/TH-positive neurons did not change (Figs. [1a](#Fig1){ref-type="fig"}'--d' and [3](#Fig3){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}). On the other hand, a subpopulation of FB^+^/CB^+^/NPY^+^ cells increased more than 13% (Figs. [1](#Fig1){ref-type="fig"} e'--h' and [3](#Fig3){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}). The number of FB^+^/CB^+^/SOM^+^ cells was reduced by more than 60% and FB^+^/CB^+^/VIP^+^ cells were not observed (Figs. [1i](#Fig1){ref-type="fig"}'--l', [2a](#Fig2){ref-type="fig"}'--d', and [3](#Fig3){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}).

None of the FB/CB-positive perikarya was immunopositive to NOS, LENK, SP, VAChT, GAL, and PACAP (Figs. [2e--l](#Fig2){ref-type="fig"}, [2e](#Fig2){ref-type="fig"}'--l', and [3](#Fig3){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}) in both experimental groups.

Discussion {#Sec4}
==========

The results of the present study indicate that although proliferative enteropathy had no influence on the number of CB-positive, colon-projecting IMG neurons, it had a large impact on their chemical coding pattern. For example, while CB/TH-expressing neurons were unaffected in the IMG of animals with proliferative enteropathy, CB/NPY-expressing neurons increased in number, and the numbers of CB neurons immunoreactive to SOM or VIP were reduced. Changes in chemical coding of CB neurons during proliferative enteropathy may play an important role in the adaptation of these IMG cells under pathological conditions.

The present study demonstrates that CB/TH-expressing neurons were unaffected in IMG of animals with proliferative enteropathy. CB/TH colon-projecting IMG neurons innervate the myenteric and submucous ganglia and the muscle layers, predominantly in the longitudinal muscle (Li and Masuko [@CR26]). These neurons are considered to be visceromotor neurons because the terminals of these neurons surround neurons of the enteric plexuses (Parr and Sharkey [@CR35]). They are thought to modulate or inhibit colon motility because their fibers and terminals are found around myenteric ganglion neurons which are essential for enteric reflex motor activity. For example, TH^+^ terminals form basket-like endings around cholinergic motor neurons and 5-HT-handling neurons (Gershon and Sherman [@CR19], [@CR20]; Tassicker et al. [@CR45]). Noradrenaline acts presynaptically to inhibit release of neurotransmitters in the myenteric plexus (Furness et al. [@CR18]; Manber and Gershon [@CR31]; Paton and Vizi [@CR34]; Tassicker et al. [@CR45]), but noradrenaline does not hyperpolarize myenteric neurons directly (Manber and Gershon [@CR31]; Nishi and North [@CR33]).

The present study also demonstrates that CB/NPY-expressing neurons increased in number in the IMG of animals with proliferative enteropathy. The number of NPY neurons is usually elevated in various other enteric diseases (Czaja et al. [@CR11]; Lakomy et al. [@CR23]; Majewski et al. [@CR30]). For example, experiments that examined the influence of colitis on the chemical coding of porcine prevertebral neurons revealed an increase in the number of NPY neurons (Majewski et al. [@CR30]). The numbers of enteric intramural NPY neurons are also elevated in the intestines of pigs with experimental ileitis (Czaja et al. [@CR11]). Similarly, in animals with porcine dysentery, NPY expression has been reported to be elevated in the IMG (Lakomy et al. [@CR23]). NPY has been implicated as mediator involved in the pathogenesis of numerous gastrointestinal disorders, including malabsorption, short gut, inflammatory bowel disease, and various forms of pancreatitis (Vona-Davis and McFadden [@CR49]). However, the exact physiological role of NPY in all these pathologies is not yet clear and requires further investigation. In normal conditions NPY-containing neurons of the IMG were considered vasomotor neurons because their fibers and terminals surrounded arterial vessels in the colon wall (Costa and Furness [@CR10]; Lundberg et al. [@CR29]), thus, influencing their control on arterial blood flow though the colon wall.

The results of the present study also indicate that the numbers of CB neurons immunoreactive to SOM or VIP were reduced in IMG of animals with proliferative enteropathy. SOM is considered to be anti-inflammatory and anti-nociceptive factor which may be actively involved in the pathophysiological inflammation of the intestines and possibly in other organs as well (Reubi et al. [@CR42]). Some of the postulated SOM actions include the reduction of inflammatory nociception, nociceptor excitation, and sensitization (Abd El-Aleem et al. [@CR2]; Hasler et al. [@CR22]; Pinter et al. [@CR39]; Plourde et al. [@CR40]). Moreover, SOM seems to play an important role not only in neurotransmission but also in the immune response to inflammation. For example, there is evidence that SOM downregulates the expression and release of pro-inflammatory cytokines (Blum et al. [@CR6]; Chowers et al. [@CR9]) through the modulation of lymphocyte proliferation (Stanisz et al. [@CR44]) and immunoglobulin production (ten Bokum et al. [@CR46]; Blum et al. [@CR6]). The number of VIP-expressing neurons was reduced to undetectable levels in the IMG of animals with PE. As VIP is also widely accepted as an anti-inflammatory factor (Abad et al. [@CR1]; Delgado and Ganea [@CR13]; Delgado et al. [@CR14]), an increase of the number of VIP-expressing cells could be expected, and previous studies have reported an elevation of VIP neurons in the intramural ganglia of animals afflicted with PE (Pidsudko et al. [@CR38]). The literature concerning the influence of pathological conditions on VIP-expressing neurons is incomplete and sometimes contradictory. For example, in animals with experimental *Schistosoma japonicum*-induced colitis, VIP immunoreactivity was markedly reduced in the intramural neurons (Balemba et al. [@CR3]). Moreover, in the most severely damaged regions of the intestine, the expression of this neuropeptide was undetectable (Balemba et al. [@CR3]). Conversely, VIP expression was elevated in the IMG of animals with swine dysentery (Lakomy et al. [@CR23]). However, it is important to note that in normal conditions, SOM and VIP cells of the IMG in cooperation with TH are involved in controlling and modulating the motility and glandular secretion of the colon (Costa and Furness [@CR10]; Gershon and Sherman [@CR19], [@CR20]; Lundberg et al. [@CR29]; Tassicker et al. [@CR45]).

In conclusion, the results of the present study indicate that colon-projecting IMG neurons that express CB are affected in animals with PE. The number of CB neurons expressing NPY was upregulated, while the numbers of CB neurons expressing SOM and VIP were distinctly reduced. These changes in the chemical coding of IMG neurons observed under pathological condition investigated in this study indicate adaptive mechanism(s) of the IMG neurons, promoting their survival and/or regeneration.
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